- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bird Flu Risks, Myths, and Prevention Strategies: A Conversation With the NFID's Dr Robert Hopkins
Joining us for this episode of Managed Care Cast is Robert H. Hopkins Jr, MD, medical director at the National Foundation for Infectious Diseases (NFID), who will help separate fact from fiction about avian influenza and discuss what needs to be done to prevent a future escalation.
Welcome to Managed Care Cast, where today we’re diving into a topic that’s generating national and global concern: bird flu. Despite its rarity in humans, the virus’s alarming mortality rate—nearly 50%—raises critical questions about its severity. Why is bird flu so deadly when it does infect humans, and how do factors like preexisting conditions play a role? We'll explore these questions, as well as the risks posed by current outbreaks, how avian influenza compares with other infectious diseases, and the latest on diagnostics, treatments, and vaccine development and recommendation. Joining us is Robert H. Hopkins Jr, MD, medical director at the National Foundation for Infectious Diseases (NFID) and NFID liaison to the Advisory Committee on Immunization Practices, who will help separate fact from fiction and discuss what needs to be done to prevent a future escalation.
Listen above or through one of these podcast services:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Long COVID Disparities Revealed in New Study From England
March 18th 2025A new analysis out of England shows a considerable level of uncertainty among adults who think they could have long COVID, as well that levels of the chronic condition are disproportionately higher among certain socially disadvantaged groups.
Read More
